AcuÑa, Rosalina A.

HRN: 11-70-64  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/11/2023
06/18/2023
IV
1.5g
Q6
T/C Aspiration Pneumonia
Waiting Final Action 
06/11/2023
MUPIROCIN 2%, 15G (TUBE)
06/11/2023
06/18/2023
IV
2%
BID
Ulcerating Wound
Waiting Final Action 
06/17/2023
MUPIROCIN 2%, 15G (TUBE)
06/17/2023
06/24/2023
TOPICAL
Sufficient Amount
BID
Infected Wound
Waiting Final Action 
06/17/2023
AZITHROMYCIN 500MG TABLET (TAB)
06/17/2023
06/21/2023
PO
500mg
OD
Thyroid Follicular CA With Pulmonary Mets
Waiting Final Action 
06/22/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/22/2023
06/29/2023
IV
1.5 G
Q6h
T/C Aspiration Pneumonia
Waiting Final Action 
07/15/2023
CEFTAZIDIME 1GM (VIAL)
07/15/2023
07/22/2023
IV
1gm
Q8
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: